Cargando…
Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
Background. An active device that downregulates abdominal vagal signalling has resulted in significant weight loss in feasibility studies. Objective. To prospectively evaluate the effect of intermittent vagal blocking (VBLOC) on weight loss, glycemic control, and blood pressure (BP) in obese subject...
Autores principales: | Shikora, S., Toouli, J., Herrera, M. F., Kulseng, B., Zulewski, H., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., Billington, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745954/ https://www.ncbi.nlm.nih.gov/pubmed/23984050 http://dx.doi.org/10.1155/2013/245683 |
Ejemplares similares
-
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial
por: Apovian, Caroline M., et al.
Publicado: (2016) -
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
por: Shikora, Scott A., et al.
Publicado: (2015) -
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
por: Morton, John M., et al.
Publicado: (2016) -
A ‘Music, Mind and Movement’ Program for People With Dementia: Initial Evidence of Improved Cognition
por: Brancatisano, Olivia, et al.
Publicado: (2019) -
Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO)
por: Sharaiha, Reem Z., et al.
Publicado: (2023)